Korea United Pharm Inc
KRX:033270
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
20 550
27 550
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Korea United Pharm Inc
Korea United Pharm Inc
Accrued Liabilities
Korea United Pharm Inc
Accrued Liabilities Peer Comparison
000100
326030
008930
128940
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Korea United Pharm Inc
KRX:033270
|
Accrued Liabilities
₩18.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
Yuhan Corp
KRX:000100
|
Accrued Liabilities
₩9.8B
|
CAGR 3-Years
92%
|
CAGR 5-Years
3%
|
CAGR 10-Years
23%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Accrued Liabilities
₩71.3B
|
CAGR 3-Years
25%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Science Co Ltd
KRX:008930
|
Accrued Liabilities
₩10.5B
|
CAGR 3-Years
19%
|
CAGR 5-Years
20%
|
CAGR 10-Years
16%
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Accrued Liabilities
₩55.8B
|
CAGR 3-Years
6%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Accrued Liabilities
₩10.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
See Also
What is Korea United Pharm Inc's Accrued Liabilities?
Accrued Liabilities
18.1B
KRW
Based on the financial report for Jun 30, 2024, Korea United Pharm Inc's Accrued Liabilities amounts to 18.1B KRW.
What is Korea United Pharm Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
7%
Over the last year, the Accrued Liabilities growth was 15%. The average annual Accrued Liabilities growth rates for Korea United Pharm Inc have been 11% over the past three years , 5% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet
